Pneumococcal Meningitis and Strep Treatment

Pneumococcal meningitis is a condition characterized by infection or inflammation of the meninges, membranes that protect the spinal cord and brain. Treatment of the disease typically involves addressing the presence of strep bacteria.

The Facts

Pneumococcal meningitis results from infection with Streptococcus pneumoniae bacteria, according to the U.S. National Library of Medicine.

Initial Treatments

The National Institute of Neurological Disorders and Stroke reports that rapid treatment is vital to positive outcomes for meningitis caused by strep or other bacteria. Initial treatment typically involves the use of general antibiotics including ceftriaxone.

Resistant Bacteria

In some cases, strep bacteria show resistance to initial antibiotic treatments. In these circumstances, doctors may use the medications rifampin or vancomycin, according to the U.S. National Library of Medicine.

Additional Treatments

Some individuals with bacterial meningitis require draining of infected sinuses, according to the NINDS. In some cases, swelling and increased brain pressure necessitate treatment with systemic corticosteroids.

Considerations

The U.S. National Library of Medicine notes that even with treatment, roughly 20 percent of individuals with pneumococcal meningitis will die, while another 50 percent will experience significant long-term health impacts.

References

• U.S. National Library of Medicine: National Institutes of Health: Meningitis--Pneumococcal
• National Institute of Neurological Disorders and Stroke: Meningitis and Encephalitis Fact Sheet

Resources

• Meningitis Research Foundation: Pneumococcal Meningitis